PMID- 32246443
OWN - NLM
STAT- MEDLINE
DCOM- 20200415
LR  - 20200415
IS  - 0065-2598 (Print)
IS  - 0065-2598 (Linking)
VI  - 1177
DP  - 2020
TI  - Evidence in Guidelines for Treatment of Coronary Artery Disease.
PG  - 37-73
LID - 10.1007/978-981-15-2517-9_2 [doi]
AB  - In this chapter, we focus on evidences in current guidelines for treatment of 
      coronary artery disease (CAD). In Part 1, diet and lifestyle management is 
      discussed, which plays an important role in CAD risk control, including forming 
      healthy dietary pattern, maintaining proper body weight, physical exercise, 
      smoking cessation, and so on. Part 2 elaborated on revascularization strategies 
      and medical treatments in patients presenting with acute coronary syndrome (ACS), 
      including specific AHA and ESC guidelines on ST elevation myocardial infarction 
      (STEMI) and non-ST elevation ACS (NSTE-ACS). Part 3 discussed chronic stable 
      coronary artery disease (SCAD), the treatment objective of which is a combination 
      of both symptomatic and prognostic improvement. Yet many of the recommendations 
      for SCAD are expert-based rather than evidence-based. Initial medical treatment 
      is safe and beneficial for most patients. While cumulating studies have focused 
      on optimizing pharmacological therapy (referring to nitrates, beta-blockers, 
      calcium channel blockers, antiplatelet agents, ACEI/ARB, statins, etc.), 
      education, habitual modification, and social support matters a lot for reducing 
      cardiac morbidity and mortality. Patients with moderate-to-severe symptoms and 
      complex lesions should be considered for revascularization. But practical 
      management of revascularization shall take individual characteristics, 
      preference, and compliance into consideration as well.
FAU - Jia, Sida
AU  - Jia S
AD  - Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of 
      Medical Sciences and Peking Union Medical College, Beijing, China.
FAU - Liu, Yue
AU  - Liu Y
AD  - Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of 
      Medical Sciences and Peking Union Medical College, Beijing, China.
FAU - Yuan, Jinqing
AU  - Yuan J
AD  - Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of 
      Medical Sciences and Peking Union Medical College, Beijing, China. 
      jqyuanfw@126.com.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Adv Exp Med Biol
JT  - Advances in experimental medicine and biology
JID - 0121103
SB  - IM
MH  - Acute Coronary Syndrome/therapy
MH  - Coronary Artery Disease/drug therapy/mortality/*therapy
MH  - Humans
MH  - Myocardial Ischemia/therapy
MH  - *Practice Guidelines as Topic
MH  - ST Elevation Myocardial Infarction/therapy
OTO - NOTNLM
OT  - Acute coronary syndrome
OT  - Chronic stable coronary artery disease
OT  - Coronary artery diseases
OT  - Diet
OT  - Lifestyle management
OT  - Revascularization strategies
OT  - Treatment guidelines
EDAT- 2020/04/05 06:00
MHDA- 2020/04/16 06:00
CRDT- 2020/04/05 06:00
PHST- 2020/04/05 06:00 [entrez]
PHST- 2020/04/05 06:00 [pubmed]
PHST- 2020/04/16 06:00 [medline]
AID - 10.1007/978-981-15-2517-9_2 [doi]
PST - ppublish
SO  - Adv Exp Med Biol. 2020;1177:37-73. doi: 10.1007/978-981-15-2517-9_2.